February’s top news stories
Eidos Therapeutics starts Phase III trial of AG10 in ATTR-CM Eidos Therapeutics commenced a pivotal Phase III clinical trial of…
Eidos Therapeutics starts Phase III trial of AG10 in ATTR-CM Eidos Therapeutics commenced a pivotal Phase III clinical trial of…
Janssen unblinds Phase III TITAN study for prostate cancer Janssen Pharmaceutical Companies of Johnson & Johnson unblinded the Phase III…
NIH to assess efficacy of male contraceptive skin gel The US National Institutes of Health (NIH) has provided funding for…